Stocks With The Most
Fund Put Options
| Name | Net Calls | Puts | Calls |
Return since 31 Mar ‘23 |
|
|---|---|---|---|---|---|
| $14M | $188M | $174M | 25.1% |
|
|
| $13.9M | $21.6M | $7.7M | 0.02% |
|
|
| $13.9M | $40.6M | $26.8M | 51.1% |
|
|
429
Corcept Therapeutics
CORT
$8.37B
| $13.5M | $36M | $22.5M | 263% |
|
| $13.4M | $18M | $4.54M | 27.4% |
|
|
| $13.1M | $478M | $465M | 42.7% |
|
|
| $13.1M | $101M | $87.5M | 16.9% |
|
|
| $13M | $61.6M | $48.6M | 19.7% |
|
|
| $12.9M | $24.4M | $11.4M | 31.8% |
|
|
| $12.9M | $258M | $245M | 12.3% |
|
|
436
Neurocrine Biosciences
NBIX
$13.6B
| $12.7M | $30.2M | $17.5M | 38.4% |
|
| $12.5M | $22.4M | $9.86M | 34% |
|
|
| $12.3M | $92.5M | $80.1M | 9.29% |
|
|
| $12.3M | $26.6M | $14.2M | 62.6% |
|
|
| $12.3M | $81.8M | $69.4M | 221% |
|
|
| $12.3M | $14M | $1.76M | 56.4% |
|
|
| $12.2M | $110M | $97.9M | 66% |
|
|
| $11.9M | $22.3M | $10.5M | 94.7% |
|
|
| $11.8M | $18.3M | $6.51M | 2.68% |
|
|
| $11.6M | $21.5M | $9.82M | 26% |
|
|
| $11.5M | $23.3M | $11.7M | 12.1% |
|
|
| $11.5M | $15M | $3.59M | 181% |
|
|
| $11.4M | $36.3M | $24.9M | 54.7% |
|
|
| $11.4M | $25.3M | $13.9M | 7.64% |
|
|
| $11.3M | $253M | $241M | 45.3% |
|